{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:07:44Z","timestamp":1781280464597,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"DOI":"10.1186\/s13052-026-02288-5","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:45:01Z","timestamp":1781279101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of the hemoglobin\u2013albumin\u2013lymphocyte\u2013platelet score for intravenous immunoglobulin resistance in children with Kawasaki disease"],"prefix":"10.1186","volume":"52","author":[{"given":"Kai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-0486","authenticated-orcid":false,"given":"Mingwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"17","key":"2288_CR1","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135(17):e927\u201399. https:\/\/doi.org\/10.1161\/CIR.0000000000000484.","journal-title":"Circulation"},{"issue":"7","key":"2288_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41584-020-0426-0","volume":"16","author":"M Noval Rivas","year":"2020","unstructured":"Noval Rivas M, Arditi M. Kawasaki disease: pathophysi-ology and insights from mouse models. Nat Rev Rheumatol. 2020;16(7):391\u2013405. https:\/\/doi.org\/10.1038\/s41584-020-0426-0.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2288_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cjca.2017.12.009","volume":"34","author":"C Manlhiot","year":"2018","unstructured":"Manlhiot C, O\u2019Shea S, Bernknopf B, et al. Epidemiology of Kawasaki Disease in Canada 2004 to 2014: Comparison of Surveillance Using Administrative Data vs Periodic Medical Record Review. Can J Cardiol. 2018;34(3):303\u20139. https:\/\/doi.org\/10.1016\/j.cjca.2017.12.009.","journal-title":"Can J Cardiol"},{"key":"2288_CR4","doi-asserted-by":"publisher","first-page":"e1009","DOI":"10.1542\/peds.2013-2936","volume":"133","author":"J Saundankar","year":"2014","unstructured":"Saundankar J, YimD, Itotoh B, Payne R, Maslin K, Jape G, et al. The epidemiology and clinical features of Kawasaki disease in Australia. Pediatrics. 2014;133:e1009\u2013104. https:\/\/doi.org\/10.1542\/peds.2013-2936.","journal-title":"Pediatrics"},{"key":"2288_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jpeds.2018.07.090","volume":"203","author":"SM Skochko","year":"2018","unstructured":"Skochko SM, Jain S, Sun X, et al. Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience. J Pediatr. 2018;203:408\u2013e4153. https:\/\/doi.org\/10.1016\/j.jpeds.2018.07.090.","journal-title":"J Pediatr"},{"issue":"2","key":"2288_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","volume":"27","author":"R Uehara","year":"2008","unstructured":"Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J. 2008;27(2):155\u201360. https:\/\/doi.org\/10.1097\/INF.0b013e31815922b5.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2288_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41390-021-01459-w","volume":"91","author":"U Kaya Akca","year":"2022","unstructured":"Kaya Akca U, Arslanoglu Aydin E, Aykan HH, et al. Comparison of IVIG resistance predictive models in Kawasaki disease. Pediatr Res. 2022;91(3):621\u20136. https:\/\/doi.org\/10.1038\/s41390-021-01459-w.","journal-title":"Pediatr Res"},{"issue":"4","key":"2288_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/archdischild-2014-307397","volume":"100","author":"S Davies","year":"2015","unstructured":"Davies S, Sutton N, Blackstock S, et al. Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child. 2015;100(4):366\u20138. https:\/\/doi.org\/10.1136\/archdischild-2014-307397.","journal-title":"Arch Dis Child"},{"issue":"1","key":"2288_CR9","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1038\/s41598-020-59972-7","volume":"10","author":"M Piram","year":"2020","unstructured":"Piram M, Darce Bello M, Tellier S, et al. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. Sci Rep. 2020;10(1):3125. https:\/\/doi.org\/10.1038\/s41598-020-59972-7.","journal-title":"Sci Rep"},{"issue":"2","key":"2288_CR10","doi-asserted-by":"publisher","first-page":"2264315","DOI":"10.1080\/07853890.2023.2264315","volume":"55","author":"XB Huang","year":"2023","unstructured":"Huang XB, Zhao S, Liu ZY, Xu YY, Deng F. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease. Ann Med. 2023;55(2):2264315. https:\/\/doi.org\/10.1080\/07853890.2023.2264315.","journal-title":"Ann Med"},{"key":"2288_CR11","doi-asserted-by":"publisher","first-page":"941739","DOI":"10.3389\/fmed.2022.941739","volume":"9","author":"H Wen","year":"2022","unstructured":"Wen H, Hun M, Zhao M, Han P, He Q. Serum ferritin as a crucial biomarker in the diagnosis and prognosis of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease: A systematic review and meta-analysis. Front Med (Lausanne). 2022;9:941739. https:\/\/doi.org\/10.3389\/fmed.2022.941739.","journal-title":"Front Med (Lausanne)"},{"key":"2288_CR12","doi-asserted-by":"publisher","first-page":"624802","DOI":"10.3389\/fimmu.2021.624802","volume":"12","author":"T Kitoh","year":"2021","unstructured":"Kitoh T, Ohara T, Muto T, et al. Increased pentraxin 3 levels correlate with IVIG responsiveness and coronary artery aneurysm formation in Kawasaki disease. Front Immunol. 2021;12:624802. https:\/\/doi.org\/10.3389\/fimmu.2021.624802.","journal-title":"Front Immunol"},{"key":"2288_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpeds.2016.07.035","volume":"178","author":"Y Kawamura","year":"2016","unstructured":"Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease. J Pediatr. 2016;178:281\u2013e2841. https:\/\/doi.org\/10.1016\/j.jpeds.2016.07.035.","journal-title":"J Pediatr"},{"key":"2288_CR14","doi-asserted-by":"publisher","first-page":"711007","DOI":"10.3389\/fcvm.2021.711007","volume":"8","author":"X Liu","year":"2021","unstructured":"Liu X, Shao S, Wang L, et al. Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease. Front Cardiovasc Med. 2021;8:711007. https:\/\/doi.org\/10.3389\/fcvm.2021.711007.","journal-title":"Front Cardiovasc Med"},{"issue":"38","key":"2288_CR15","doi-asserted-by":"publisher","first-page":"41370","DOI":"10.18632\/oncotarget.5629","volume":"6","author":"XL Chen","year":"2015","unstructured":"Chen XL, Xue L, Wang W, et al. Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget. 2015;6(38):41370\u201382. https:\/\/doi.org\/10.18632\/oncotarget.5629.","journal-title":"Oncotarget"},{"issue":"1","key":"2288_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41598-018-19146-y","volume":"8","author":"D Peng","year":"2018","unstructured":"Peng D, Zhang CJ, Gong YQ, et al. Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy. Sci Rep. 2018;8(1):794. https:\/\/doi.org\/10.1038\/s41598-018-19146-y.","journal-title":"Sci Rep"},{"issue":"4","key":"2288_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3748\/wjg.v27.i4.321","volume":"27","author":"SJ Hu","year":"2021","unstructured":"Hu SJ, Zhao XK, Song X, et al. Preoperative maximal voluntary ventilation, hemoglobin, albumin, lymphocytes and platelets predict postoperative survival in esophageal squamous cell carcinoma. World J Gastroenterol. 2021;27(4):321\u201335. https:\/\/doi.org\/10.3748\/wjg.v27.i4.321.","journal-title":"World J Gastroenterol"},{"key":"2288_CR18","doi-asserted-by":"publisher","first-page":"1241217","DOI":"10.3389\/fcvm.2023.1241217","volume":"10","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Huang Y, Li H. Hemoglobin albumin lymphocyte and platelet score and all-cause mortality in coronary heart disease: a retrospective cohort study of NHANES database. Front Cardiovasc Med. 2023;10:1241217. https:\/\/doi.org\/10.3389\/fcvm.2023.1241217.","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"2288_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/MCA.0000000000001271","volume":"34","author":"M Karakayali","year":"2023","unstructured":"Karakayali M, Omar T, Artac I, et al. The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coron Artery Dis. 2023;34(7):483\u20138. https:\/\/doi.org\/10.1097\/MCA.0000000000001271.","journal-title":"Coron Artery Dis"},{"key":"2288_CR20","doi-asserted-by":"publisher","unstructured":"Li H, Zhou Y, Zhang X, Yao R, Li N. The relationship between hemoglobin, albumin, lymphocyte, and platelet (HALP) score and 28-day mortality in patients with sepsis: a retrospective analysis of the MIMIC-IV database. BMC Infect Dis. 2025;25(1):333. Published 2025 Mar 10. https:\/\/doi.org\/10.1186\/s12879-025-10739-3.","DOI":"10.1186\/s12879-025-10739-3"},{"issue":"23","key":"2288_CR21","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","volume":"150","author":"PN Jone","year":"2024","unstructured":"Jone PN, Tremoulet A, Choueiter N, et al. Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association. Circulation. 2024;150(23):e481\u2013500. https:\/\/doi.org\/10.1161\/CIR.0000000000001295.","journal-title":"Circulation"},{"key":"2288_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.echo.2010.10.004","volume":"24","author":"F Dallaire","year":"2011","unstructured":"Dallaire F, Dahdah N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr. 2011;24:60\u201374. https:\/\/doi.org\/10.1016\/j.echo.2010.10.004.","journal-title":"J Am Soc Echocardiogr"},{"key":"2288_CR23","volume-title":"Nelson Textbook of Pediatrics","author":"RM Kliegman","year":"2024","unstructured":"Kliegman RM, St. Geme JW III, Blum NJ, Tasker RC, Wilson KM, Schuh AM, et al. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia: Elsevier; 2024.","edition":"22"},{"issue":"3","key":"2288_CR24","doi-asserted-by":"publisher","first-page":"e0248812","DOI":"10.1371\/journal.pone.0248812","volume":"16","author":"X Zheng","year":"2021","unstructured":"Zheng X, Li J, Yue P, et al. Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis. PLoS ONE. 2021;16(3):e0248812. https:\/\/doi.org\/10.1371\/journal.pone.0248812. Published 2021 Mar 25.","journal-title":"PLoS ONE"},{"key":"2288_CR25","doi-asserted-by":"publisher","first-page":"812644","DOI":"10.3389\/fped.2022.812644","volume":"10","author":"J Liu","year":"2022","unstructured":"Liu J, Huang Y, Chen C, Su D, Qin S, Pang Y. Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study. Front Pediatr. 2022;10:812644. https:\/\/doi.org\/10.3389\/fped.2022.812644. Published 2022 Apr 20.","journal-title":"Front Pediatr"},{"issue":"9826","key":"2288_CR26","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613\u201320. https:\/\/doi.org\/10.1016\/S0140-6736(11)61930-2.","journal-title":"Lancet"},{"issue":"12","key":"2288_CR27","doi-asserted-by":"publisher","first-page":"e009562","DOI":"10.1136\/bmjopen-2015-009562","volume":"5","author":"R Aoyagi","year":"2015","unstructured":"Aoyagi R, Hamada H, Sato Y, et al. Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial). BMJ Open. 2015;5(12):e009562. https:\/\/doi.org\/10.1136\/bmjopen-2015-009562. Published 2015 Dec 1.","journal-title":"BMJ Open"},{"issue":"1","key":"2288_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12969-025-01108-0","volume":"23","author":"S Hatano","year":"2025","unstructured":"Hatano S, Nakao H, Masuda H, Ono H, Kubota M, Ishiguro A. Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study. Pediatr Rheumatol Online J. 2025;23(1):49. https:\/\/doi.org\/10.1186\/s12969-025-01108-0. Published 2025 May 13.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"2288_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1067\/mpd.2000.104815","volume":"137","author":"M Fukunishi","year":"2000","unstructured":"Fukunishi M, Kikkawa M, Hamana K, et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr. 2000;137(2):172\u20136. https:\/\/doi.org\/10.1067\/mpd.2000.104815.","journal-title":"J Pediatr"},{"issue":"1","key":"2288_CR30","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1080\/07853890.2022.2031273","volume":"54","author":"H Huang","year":"2022","unstructured":"Huang H, Jiang J, Shi X, et al. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China. Ann Med. 2022;54(1):442\u201353. https:\/\/doi.org\/10.1080\/07853890.2022.2031273.","journal-title":"Ann Med"},{"issue":"Pt A","key":"2288_CR31","doi-asserted-by":"publisher","first-page":"107037","DOI":"10.1016\/j.intimp.2020.107037","volume":"89","author":"G Li","year":"2020","unstructured":"Li G, Wang T, Gou Y, et al. Value of C-reactive protein\/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China. Int Immunopharmacol. 2020;89(Pt A):107037. https:\/\/doi.org\/10.1016\/j.intimp.2020.107037.","journal-title":"Int Immunopharmacol"},{"key":"2288_CR32","doi-asserted-by":"crossref","unstructured":"Alves NR, Magalh\u00e3es CM, Almeida Rde F, Santos RC, Gandolfi L, Pratesi R. Prospective study of Kawasaki disease complications: review of 115 cases. Rev Assoc Med Bras (1992). 2011;57(3):295\u2013300.","DOI":"10.1016\/S0104-4230(11)70062-8"},{"issue":"4","key":"2288_CR33","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1399-3038.2007.00516.x","volume":"18","author":"HC Kuo","year":"2007","unstructured":"Kuo HC, Yang KD, Liang CD, et al. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol. 2007;18(4):354\u20139. https:\/\/doi.org\/10.1111\/j.1399-3038.2007.00516.x.","journal-title":"Pediatr Allergy Immunol"},{"key":"2288_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pep.2015.04.016","volume":"115","author":"M Boumaiza","year":"2015","unstructured":"Boumaiza M, Jaouen M, Deschemin JC, et al. Expression and purification of a new recombinant camel hepcidin able to promote the degradation of the iron exporter ferroportin1. Protein Expr Purif. 2015;115:11\u20138. https:\/\/doi.org\/10.1016\/j.pep.2015.04.016.","journal-title":"Protein Expr Purif"},{"issue":"18","key":"2288_CR35","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1182\/blood-2010-03-271791","volume":"116","author":"SN Song","year":"2010","unstructured":"Song SN, Tomosugi N, Kawabata H, Ishikawa T, Nishikawa T, Yoshizaki K. Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease. Blood. 2010;116(18):3627\u201334. https:\/\/doi.org\/10.1182\/blood-2010-03-271791.","journal-title":"Blood"},{"issue":"4","key":"2288_CR36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s10875-012-9668-1","volume":"32","author":"HC Kuo","year":"2012","unstructured":"Kuo HC, Yang YL, Chuang JH, et al. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. J Clin Immunol. 2012;32(4):746\u201352. https:\/\/doi.org\/10.1007\/s10875-012-9668-1.","journal-title":"J Clin Immunol"},{"issue":"8","key":"2288_CR37","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.1097\/INF.0b013e31828e887f","volume":"32","author":"PP Fu","year":"2013","unstructured":"Fu PP, Du ZD, Pan YS. Novel predictors of intravenous immunoglobulin resistance in Chinese children with Kawasaki disease. Pediatr Infect Dis J. 2013;32(8):e319\u201323. https:\/\/doi.org\/10.1097\/INF.0b013e31828e887f.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2288_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/archdischild-2017-314512","volume":"104","author":"S Yang","year":"2019","unstructured":"Yang S, Song R, Zhang J, Li X, Li C. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing. Arch Dis Child. 2019;104(3):262\u20137. https:\/\/doi.org\/10.1136\/archdischild-2017-314512.","journal-title":"Arch Dis Child"},{"issue":"6","key":"2288_CR39","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.0894-0959.2004.17603.x","volume":"17","author":"BR Don","year":"2004","unstructured":"Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432\u20137. https:\/\/doi.org\/10.1111\/j.0894-0959.2004.17603.x.","journal-title":"Semin Dial"},{"issue":"10","key":"2288_CR40","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295. Published 2014 Sep 4.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"2288_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","volume":"43","author":"PB Soeters","year":"2019","unstructured":"Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enter Nutr. 2019;43(2):181\u201393. https:\/\/doi.org\/10.1002\/jpen.1451.","journal-title":"JPEN J Parenter Enter Nutr"},{"issue":"1","key":"2288_CR42","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41598-019-39330-y","volume":"9","author":"XH Tan","year":"2019","unstructured":"Tan XH, Zhang XW, Wang XY, et al. A new model for predicting intravenous immunoglobin-resistant Kawasaki disease in Chongqing: a retrospective study on 5277 patients. Sci Rep. 2019;9(1):1722. https:\/\/doi.org\/10.1038\/s41598-019-39330-y. Published 2019 Feb 11.","journal-title":"Sci Rep"},{"issue":"6","key":"2288_CR43","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12519-020-00348-2","volume":"16","author":"S Wu","year":"2020","unstructured":"Wu S, Liao Y, Sun Y, et al. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children. World J Pediatr. 2020;16(6):607\u201313. https:\/\/doi.org\/10.1007\/s12519-020-00348-2.","journal-title":"World J Pediatr"},{"issue":"2","key":"2288_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12016-019-08740-1","volume":"58","author":"S Hillion","year":"2020","unstructured":"Hillion S, Arleevskaya MI, Blanco P, et al. The Innate Part of the Adaptive Immune System. Clin Rev Allergy Immunol. 2020;58(2):151\u20134. https:\/\/doi.org\/10.1007\/s12016-019-08740-1.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"21","key":"2288_CR45","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.2174\/092986711796391633","volume":"18","author":"J N\u00fa\u00f1ez","year":"2011","unstructured":"N\u00fa\u00f1ez J, Mi\u00f1ana G, Bod\u00ed V, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226\u201333. https:\/\/doi.org\/10.2174\/092986711796391633.","journal-title":"Curr Med Chem"},{"issue":"1","key":"2288_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/mca.0b013e328332ee15","volume":"21","author":"J N\u00fa\u00f1ez","year":"2010","unstructured":"N\u00fa\u00f1ez J, N\u00fa\u00f1ez E, Bod\u00ed V, et al. Low lymphocyte count in acute phase of ST-segment elevation myocardial infarction predicts long-term recurrent myocardial infarction. Coron Artery Dis. 2010;21(1):1\u20137. https:\/\/doi.org\/10.1097\/mca.0b013e328332ee15.","journal-title":"Coron Artery Dis"},{"issue":"11","key":"2288_CR47","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113(11):1424\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.584102.","journal-title":"Circulation"},{"issue":"1","key":"2288_CR48","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2019.09.003","volume":"7","author":"K Arora","year":"2019","unstructured":"Arora K, Guleria S, Jindal AK, Rawat A, Singh S. Platelets in Kawasaki disease: Is this only a numbers game or something beyond? Genes Dis. 2019;7(1):62\u20136. https:\/\/doi.org\/10.1016\/j.gendis.2019.09.003. Published 2019 Sep 12.","journal-title":"Genes Dis"},{"issue":"2","key":"2288_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.blre.2006.06.001","volume":"21","author":"A Zarbock","year":"2007","unstructured":"Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev. 2007;21(2):99\u2013111. https:\/\/doi.org\/10.1016\/j.blre.2006.06.001.","journal-title":"Blood Rev"},{"issue":"8","key":"2288_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/0003319713502392","volume":"65","author":"M Laurito","year":"2014","unstructured":"Laurito M, Stazi A, Delogu AB, et al. Endothelial and platelet function in children with previous Kawasaki disease. Angiology. 2014;65(8):716\u201322. https:\/\/doi.org\/10.1177\/0003319713502392.","journal-title":"Angiology"},{"issue":"7","key":"2288_CR51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3346\/jkms.2017.32.7.1147","volume":"32","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Choi EH, Lim YJ, Kil HR. The Usefulness of Platelet-derived Microparticle as Biomarker of Antiplatelet Therapy in Kawasaki Disease. J Korean Med Sci. 2017;32(7):1147\u201353. https:\/\/doi.org\/10.3346\/jkms.2017.32.7.1147.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"2288_CR52","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s10067-020-05361-4","volume":"40","author":"QM Zhao","year":"2021","unstructured":"Zhao QM, Huang M, Huang MR, et al. Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range. Clin Rheumatol. 2021;40(4):1515\u201323. https:\/\/doi.org\/10.1007\/s10067-020-05361-4.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"2288_CR53","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2188\/jea.JE20190065","volume":"30","author":"LP Xie","year":"2020","unstructured":"Xie LP, Yan WL, Huang M, et al. Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017. J Epidemiol. 2020;30(10):429\u201335. https:\/\/doi.org\/10.2188\/jea.JE20190065.","journal-title":"J Epidemiol"},{"key":"2288_CR54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fped.2020.00470","volume":"8","author":"Y Tang","year":"2020","unstructured":"Tang Y, Li X, Cao L, et al. Characteristics and Indications of Kawasaki Disease Among Infants Under 6 Months. Front Pediatr. 2020;8:470. https:\/\/doi.org\/10.3389\/fped.2020.00470. Published 2020 Aug 14.","journal-title":"Front Pediatr"},{"issue":"1","key":"2288_CR55","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1542\/peds.102.1.e7","volume":"102","author":"T Momenah","year":"1998","unstructured":"Momenah T, Sanatani S, Potts J, Sandor GG, Human DG, Patterson MW. Kawasaki disease in the older child. Pediatrics. 1998;102(1):e7. https:\/\/doi.org\/10.1542\/peds.102.1.e7.","journal-title":"Pediatrics"},{"issue":"2","key":"2288_CR56","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1067\/mpd.2000.105150","volume":"137","author":"JA Stockheim","year":"2000","unstructured":"Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. J Pediatr. 2000;137(2):250\u20132. https:\/\/doi.org\/10.1067\/mpd.2000.105150.","journal-title":"J Pediatr"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-026-02288-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-026-02288-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:45:06Z","timestamp":1781279106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-026-02288-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2288"],"URL":"https:\/\/doi.org\/10.1186\/s13052-026-02288-5","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Anhui Provincial Hospital (No. 2025-re378). Informed consent was waived because of its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors have any personal, financial, commercial, or academic conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"104"}}